Right now, tens of thousands of Americans with end-stage kidney disease spend years waiting for a viable transplant, which are rare and mostly come from deceased organ donors or patients' family members. But "there's not really a shortage" of kidneys, Nobel laureate economist Alvin Roth told Reason's Nick Gillespie in a recent interview. "You have two. You only need one. There's a failure of price mechanisms."
